Keltjens also previously served in various leadership roles at Cordis, a Johnson & Johnson company, including his last position as Worldwide General Manager of Cordis Neurovascular.
“On behalf of the Board of Directors, I would like to thank Eamonn for all his contributions to AngioDynamics, both as the company’s co-founder and previous chief executive officer, as well as most recently as a member of the Board. We all wish him the very best in his future endeavors,” said Vincent Bucci, chairman of the board of directors. “At the same time, the Board looks forward to working with Jan in his expanded role with AngioDynamics. During his short tenure as our president and chief executive officer, his performance has reinforced the Board’s confidence in his leadership of the Company.”
